Prescient Therapeutics Initiates Phase 1b Clinical Trial for First-in Class Anti-Cancer Drug PTX-100 in Patients with Multiple Cancers
Highlights: Innovative ‘basket’ study design will assess drug in multiple cancers Precision medicine approach offers...